Participants will learn how to overcome the barriers which may slow the uptake and diffusion of biomarker-based technologies in the drug discovery and development. Speakers and delegates from Big Pharma will attend.

Key topics

• Embrace the latest developments in biomarkers regulations, validation and qualification
• New Approaches in Imaging
• Softwares to support capture of large datasets
• Embrace the route of biomarker from discovery to development
• Circulating tumor cells – solution for improving the treatment of cancer
• Urgent need of biomarkers research in Parkinson’s disease and Alzheimer’s disease